Surgical Debulking of Pituitary Adenomas
Completed · Phase 4
Conditions studied: Pituitary Adenoma
In brief
This is a randomized, multicenter trial with stratification done by a single radiologist at the coordinating center (NYU), and patients with comparable disease will be randomized to Sandostatin LAR treatment administered 1 time per month by IM injection for 3 months before (Arm A) or, for non-cured patients, after (Arm B) surgery. All patients will undergo transsphenoidal hypophysectomy. The impact of surgical debulking on responsiveness to Sandostatin LAR will be evaluated.The primary objective of this trial will be to determine whether surgery (debulking of pituitary adenomas) improves the response of patients with acromegaly to treatment with Octreotide LAR, when compared to Octreotide LAR therapy alone.
Key facts
- Study ID
- NCT01371643
- Run by
- NYU Langone Health
- People needed
- 41
- Starts
- 2004-04-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2016-08-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Carry a diagnosis of de novo acromegaly with an elevated age and sex matched IGF-I and GH >1ng/ml at all time points during OGTT
- Have a pituitary macroadenoma
- Have clinical changes consistent with acromegaly
- Have a single random serum hGH of 12.5 ng/ml or greater
- Both the endocrinologist and surgeon must agree that the patient's health would not be compromised by a three-month period during which time Octreotide LAR is administered.
- Patients currently on dopamine agonist who agree to discontinue medication (2-6 week washout required)
You may not qualify if…
- Pregnant or breastfeeding
- Documented loss of vision due to pituitary tumor
- Prior treatment for acromegaly other than dopamine agonists
- Inability to complete the protocol
- Intolerance to octreotide
Where it is running
- New York University School of Medicine — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.